Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study
<p>Abstract</p> <p>Background</p> <p>The goal of this research was to compare the demographics, clinical characteristics and treatment patterns for newly diagnosed multiple sclerosis (MS) patients in a commercial managed care population who received disease-modifying dr...
Main Authors: | Kassed Cheryl A, Johnson Barbara H, Fowler Robert, Margolis Jay M, Kahler Kristijan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/11/122 |
Similar Items
-
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance–A retrospective cohort study
by: Scott D. Ramsey, et al.
Published: (2022-01-01) -
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
by: Scott D Ramsey, et al.
Published: (2022-01-01) -
Causes of death among commercially insured multiple sclerosis patients in the United States.
by: Douglas S Goodin, et al.
Published: (2014-01-01) -
Neighborhood socioeconomic status and postpartum depression among commercial health insurance enrollees: a retrospective cohort study
by: Onur Baser, et al.
Published: (2024-11-01) -
Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study
by: Laurence Mainville, et al.
Published: (2025-02-01)